272 related articles for article (PubMed ID: 27197253)
1. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.
Lim S; Liu H; Madeira da Silva L; Arora R; Liu Z; Phillips JB; Schmitt DC; Vu T; McClellan S; Lin Y; Lin W; Piazza GA; Fodstad O; Tan M
Cancer Res; 2016 Apr; 76(8):2231-42. PubMed ID: 27197253
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.
Liu Z; Zhang W; Phillips JB; Arora R; McClellan S; Li J; Kim JH; Sobol RW; Tan M
Oncogene; 2019 Jan; 38(1):88-102. PubMed ID: 30082909
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.
Nunes-Xavier CE; Karlsen KF; Tekle C; Pedersen C; Øyjord T; Hongisto V; Nesland JM; Tan M; Sahlberg KK; Fodstad Ø
Oncotarget; 2016 Feb; 7(6):6891-901. PubMed ID: 26771843
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
Tekle C; Nygren MK; Chen YW; Dybsjord I; Nesland JM; Maelandsmo GM; Fodstad O
Int J Cancer; 2012 May; 130(10):2282-90. PubMed ID: 21671471
[TBL] [Abstract][Full Text] [Related]
6. The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway.
Li Z; Liu J; Que L; Tang X
J Cancer; 2019; 10(23):5770-5784. PubMed ID: 31737114
[TBL] [Abstract][Full Text] [Related]
7. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
[TBL] [Abstract][Full Text] [Related]
8. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
10. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA
Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
12. B7-H3 Regulates Glucose Metabolism in Neuroblastom via Stat3/c-Met Pathway.
Zhu X; Shi Y; Wang J
Appl Biochem Biotechnol; 2024 Mar; 196(3):1386-1398. PubMed ID: 37405686
[TBL] [Abstract][Full Text] [Related]
13. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization.
Lim JH; Luo C; Vazquez F; Puigserver P
Cancer Res; 2014 Jul; 74(13):3535-45. PubMed ID: 24812272
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 Immune Checkpoint Protein in Human Cancer.
Flem-Karlsen K; Fodstad Ø; Nunes-Xavier CE
Curr Med Chem; 2020; 27(24):4062-4086. PubMed ID: 31099317
[TBL] [Abstract][Full Text] [Related]
16. Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress.
Sasaki Y; Takagane K; Konno T; Itoh G; Kuriyama S; Yanagihara K; Yashiro M; Yamada S; Murakami S; Tanaka M
Cancer Sci; 2021 Mar; 112(3):1251-1261. PubMed ID: 33393151
[TBL] [Abstract][Full Text] [Related]
17. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization.
Finley LW; Carracedo A; Lee J; Souza A; Egia A; Zhang J; Teruya-Feldstein J; Moreira PI; Cardoso SM; Clish CB; Pandolfi PP; Haigis MC
Cancer Cell; 2011 Mar; 19(3):416-28. PubMed ID: 21397863
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
[TBL] [Abstract][Full Text] [Related]
19. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
[TBL] [Abstract][Full Text] [Related]
20. Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization.
Wei L; Zhou Y; Qiao C; Ni T; Li Z; You Q; Guo Q; Lu N
Cell Death Dis; 2015 Apr; 6(4):e1714. PubMed ID: 25855962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
